Washington—Medicare officials Dec. 16 announced a delay in PECOS enforcement to at least July 5, 2011, “to give CMS more flexibility to determine the appropriate date for nonpayment of claims that fail the ordering/referring provider edits.”
Gaithersburg, Md.—The Association commended an advisory panel’s
call for continued research while offering support for the Food and Drug
Administration’s current amalgam regulation. The panel found that FDA
acted appropriately in ruling last year that dental amalgam is a safe
and effective treatment option for the general population.
Gaithersburg, Md.—The ADA testified Tuesday before a U.S. Food and Drug Administration Advisory Panel tasked with assessing whether amalgam regulations issued in 2009 accurately represented the strengths and weaknesses of available data.
